Not applicableStudy completedNCT04912817What this trial is testingPR-VR At-home Program During and After COVID-19Who this might be right forPain, Chronic The Hospital for Sick Children 40
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07567274What this trial is testingDMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine InjuryWho this might be right forTinnitus Leading Edge Clinic 20
Large-scale testing (Phase 3)Study completedNCT01854697What this trial is testingEvaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment BeforeWho this might be right forChronic Hepatitis C Infection AbbVie 311
Testing effectiveness (Phase 2)Study completedNCT01180790What this trial is testingSafety, Tolerability, and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in Hepatitis C Virus (HCV) Positive ParticipantsWho this might be right forHepatitis C Alexion Pharmaceuticals, Inc. 122
Post-approval studies (Phase 4)Study completedNCT00353418What this trial is testingPEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infectionWho this might be right forHepatitis C, Chronic Hoffmann-La Roche 415
Not applicableStudy completedNCT01525810What this trial is testingThree-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical TrialWho this might be right forHepatitis C Bristol-Myers Squibb 218
Testing effectiveness (Phase 2)Study completedNCT01026610What this trial is testingSafety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis BWho this might be right forChronic Hepatitis B LG Life Sciences 115
Large-scale testing (Phase 3)Study completedNCT03186313What this trial is testingEvaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus Or Dactavira in Egyptian Adults With Chronic Genotype 4 HCV InfectionWho this might be right forHepatitis C Egyptian Liver Hospital 72
Not applicableUnknownNCT05095090What this trial is testingStudy of Hospitalised Patients With Acute Respiratory ConditionsWho this might be right forAcute Respiratory DiseaseCOPD Exacerbation AcuteAsthma+1 more University of Leicester 130
Not applicableUnknownNCT01157910What this trial is testingBacterial Assessment of Middle Ear Fluid in Children Undergoing Ventilation Tube Placement SurgeryWho this might be right forChronic Otitis MediaAge Determined Bacteria Hillel Yaffe Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT01987453What this trial is testingLedipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Participants With Chronic Genotype 1 HCV Who Participated in a Prior Gilead-Sponsored HCV Treatment StudyWho this might be right forHCV Infection Gilead Sciences 100
Not applicableStudy completedNCT04874753What this trial is testingThe Effect of COVID-19 Pandemia on Follow up of Patients With Chronic Kidney DiseaseWho this might be right forCovid19Chronic Kidney DiseasesProteinuria Uşak University 200
Testing effectiveness (Phase 2)Study completedNCT02430194What this trial is testingLonafarnib Boosted With Ritonavir With and Without Peginterferon Alfa-2a (PEG IFN-a) in HDV (LOWR-2)Who this might be right forChronic Hepatitis D Infection Eiger BioPharmaceuticals 55
Large-scale testing (Phase 3)Not Yet RecruitingNCT07797231What this trial is testingClinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor ResponseWho this might be right forChronic Hepatitis B Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 930
Testing effectiveness (Phase 2)Study completedNCT02765802What this trial is testingEvaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus InfectionWho this might be right forHepatitis D, Chronic EIT Pharma, Inc. 33
Early research (Phase 1)Study completedNCT00117429What this trial is testingStudy of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)Who this might be right forHIV Infections Marcus Altfeld, M.D., Ph.D. 20
Testing effectiveness (Phase 2)UnknownNCT04202653What this trial is testingCombination of ETV, TQ-A3334 and TQ-B2450 for CHB (Neptune Study)Who this might be right forChronic Hepatitis b Tongji Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01974687What this trial is testingSingle and Multiple Dose Study of Uprifosbuvir (MK-3682/IDX21437) in Healthy and Hepatitis C Virus (HCV)-Infected Participants (MK-3682-001)Who this might be right forChronic Hepatitis C Merck Sharp & Dohme LLC 178
Not applicableStudy completedNCT03345498What this trial is testingEntecavir for Decompensated HBV CirrhosisWho this might be right forHepatitis BLiver Cirrhosis Sanjay Gandhi Postgraduate Institute of Medical Sciences 32
Testing effectiveness (Phase 2)Study completedNCT01314014What this trial is testingImexon for Relapsed Follicular and Aggressive LymphomasWho this might be right forFollicular LymphomaSmall Lymphocytic LymphomaMarginal Zone Lymphoma+4 more University of Rochester 22